About this trial
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Eligibility criteria
Qualifiers
Presenting to the urology clinic for catheter removal
Must be 18 years or older.
The patient must be able to understand and willing to provide informed consent as described in this study protocol.
Must be willing to complete a post-catheter removal survey
Disqualifiers
Allergy or adverse reaction to chlorohexidine gluconate
Under the age of 18
Refuse to provide informed consent
On antibiotic therapy for any indication.
Trial design
Treatments tested in this trial
- 0.05% Chlorhexidine Gluconate
- Normal Saline
Treatment groups
Sponsors and collaborators
Ohio State University
Lead sponsor
Irrimax Corporation
Collaborator